調查批次:CHT2017-03 | 檢體寄出日期:2017-06-26 | 報告回收截止日期:2017-07-03 | 回收份數:22 |
FT4 檢驗院際品管調查結果: | ||
2.歷次品管檢體 FT4 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 1 |
2 |
5 |
1.63 |
-0.20 |
-10.9 |
-1.4 |
0.1 |
-46 |
1.83 |
-0.17 |
-8.5 |
-1.1 |
0.1 |
-35 |
RH07b | RH07 | 4 |
2 |
3 |
1.85 |
0.02 |
1.1 |
0.1 |
1.4 |
5 |
2.12 |
0.12 |
6.0 |
0.8 |
2.3 |
25 |
RH14 | RH14 | 4 |
2 |
3 |
1.79 |
-0.04 |
-2.2 |
-0.3 |
1.0 |
-9 |
1.89 |
-0.11 |
-5.5 |
-0.7 |
0.5 |
-23 |
RH15 | RH15 | 7 |
2 |
5 |
1.61 |
-0.22 |
-12.0 |
-1.5 |
0.0 |
-50 |
1.76 |
-0.24 |
-12.0 |
-1.5 |
-0.5 |
-50 |
CL009 | CL009 | 4 |
2 |
5 |
1.57 |
-0.26 |
-14.2 |
-1.8 |
-0.2 |
-59 |
1.73 |
-0.27 |
-13.5 |
-1.7 |
-0.7 |
-56 |
CL010 | CL010 | 7 |
2 |
5 |
1.40 |
-0.43 |
-23.5 |
-2.9 |
-1.2 |
-98 |
1.54 |
-0.46 |
-23.0 |
-2.9 |
-2.1 |
-96 |
CL012 | CL012 | 8 |
2 |
3 |
1.50 |
-0.33 |
-18.0 |
-2.3 |
-0.6 |
-75 |
1.82 |
-0.18 |
-9.0 |
-1.1 |
0.0 |
-38 |
CL015 | CL015 | 7 |
2 |
3 |
1.50 |
-0.33 |
-18.0 |
-2.3 |
-0.6 |
-75 |
1.87 |
-0.13 |
-6.5 |
-0.8 |
0.4 |
-27 |
Median of RIA Group |
1.59 |
1.83 |
||||||||||||||
Range of RIA Group |
1.40 - 1.85 |
1.54 - 2.12 |
||||||||||||||
Robust mean of RIA Group |
1.61 ( n = 8 ) |
1.82 ( n = 8 ) |
||||||||||||||
Robust SD of RIA Group |
0.172 |
0.132 |
||||||||||||||
CV of RIA Group |
10.7% |
7.3% |
||||||||||||||
Median of European RIA Labs |
1.71 ( n = 104 ) |
1.88 ( n = 113 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
1.59 - 1.90 |
1.70 - 2.07 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 3 |
4 |
9 |
1.93 |
0.10 |
5.5 |
0.7 |
0.9 |
23 |
2.03 |
0.03 |
1.5 |
0.2 |
0.8 |
6 |
RH02c | RH02 | 3 |
4 |
1 |
1.53 |
-0.30 |
-16.4 |
-2.1 |
-0.6 |
-68 |
1.64 |
-0.36 |
-18.0 |
-2.3 |
-0.7 |
-75 |
RH06 | RH06 | 7 |
4 |
9 |
2.04 |
0.21 |
11.5 |
1.4 |
1.3 |
48 |
2.16 |
0.16 |
8.0 |
1.0 |
1.4 |
33 |
RH07a | RH07 | 7 |
4 |
2 |
1.37 |
-0.46 |
-25.1 |
-3.2 |
-1.2 |
-105 |
1.55 |
-0.45 |
-22.5 |
-2.8 |
-1.1 |
-94 |
RH12 | RH12 | 4 |
4 |
2 |
1.55 |
-0.28 |
-15.3 |
-1.9 |
-0.5 |
-64 |
1.68 |
-0.32 |
-16.0 |
-2.0 |
-0.6 |
-67 |
RH15b | RH15b | 4 |
4 |
13 |
1.94 |
0.11 |
6.0 |
0.8 |
1.0 |
25 |
2.07 |
0.07 |
3.5 |
0.4 |
1.0 |
15 |
RH19 | RH19 | 7 |
4 |
2 |
1.52 |
-0.31 |
-16.9 |
-2.1 |
-0.7 |
-71 |
1.69 |
-0.31 |
-15.5 |
-1.9 |
-0.5 |
-65 |
RH20 | RH20 | 7 |
4 |
7 |
1.69 |
-0.14 |
-7.7 |
-1.0 |
0.0 |
-32 |
1.74 |
-0.26 |
-13.0 |
-1.6 |
-0.3 |
-54 |
CL005 | CL005 | 4 |
4 |
9 |
2.02 |
0.19 |
10.4 |
1.3 |
1.3 |
43 |
2.13 |
0.13 |
6.5 |
0.8 |
1.2 |
27 |
CL006a | CL006 | 7 |
4 |
7 |
1.57 |
-0.26 |
-14.2 |
-1.8 |
-0.5 |
-59 |
1.69 |
-0.31 |
-15.5 |
-1.9 |
-0.5 |
-65 |
CL008 | CL008 | 7 |
4 |
2 |
1.59 |
-0.24 |
-13.1 |
-1.6 |
-0.4 |
-55 |
1.71 |
-0.29 |
-14.5 |
-1.8 |
-0.4 |
-60 |
CL011 | CL011 | 1 |
4 |
13 |
1.93 |
0.10 |
5.5 |
0.7 |
0.9 |
23 |
2.09 |
0.09 |
4.5 |
0.6 |
1.1 |
19 |
CL013b | CL013b | 4 |
4 |
1 |
1.48 |
-0.35 |
-19.1 |
-2.4 |
-0.8 |
-80 |
1.63 |
-0.37 |
-18.5 |
-2.3 |
-0.8 |
-77 |
CL014b | CL014 | 2 |
4 |
1 |
1.52 |
-0.31 |
-16.9 |
-2.1 |
-0.7 |
-71 |
1.65 |
-0.35 |
-17.5 |
-2.2 |
-0.7 |
-73 |
Median of CLIA Group |
1.58 |
1.70 |
||||||||||||||
Range of CLIA Group |
1.37 - 2.04 |
1.55 - 2.16 |
||||||||||||||
Robust mean of CLIA Group |
1.69 ( n = 14 ) |
1.82 ( n = 14 ) |
||||||||||||||
Robust SD of CLIA Group |
0.260 |
0.250 |
||||||||||||||
CV of CLIA Group |
15.4% |
13.7% |
||||||||||||||
Median of European CLIA Labs |
1.85 ( n = 1056 ) |
2.04 ( n = 1080 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
1.48 - 1.97 |
1.56 - 2.18 |
||||||||||||||
Median of All Labs |
1.58 |
1.75 |
||||||||||||||
Range of All Labs |
1.37 - 2.04 |
1.54 - 2.16 |
||||||||||||||
Robust mean of All Labs |
1.66 ( n = 22 ) |
1.82 ( n = 22 ) |
||||||||||||||
Robust SD of All Labs |
0.226 |
0.224 |
||||||||||||||
CV of All Labs |
13.6% |
12.3%
|
||||||||||||||
Median of All European Labs ( Xa ) |
1.83 |
2.00 |
||||||||||||||
uXa |
0.008 |
0.010 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
1.48 - 1.97 |
1.58 - 2.18 |
||||||||||||||
Mean of All European Labs |
1.75 ( n = 1216 ) |
1.91 ( n = 1257 ) |
||||||||||||||
SD of All European Labs |
0.228 |
0.272 |
||||||||||||||
CV of All European Labs |
13.0% |
14.3% |
||||||||||||||
SD for proficiency assessment ( σp ) |
0.146 |
0.160 |
||||||||||||||
Adjusted SD for proficiency assessment ( σp ' ) |
- |
- |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH15b, RH19, RH20, CL005, CL006a, CL008, CL011, CL013b, CL014b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL013b, CL014b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL015, |
Immunotech |
5 |
RH01b, RH15, CL009, CL010, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
RH15b, CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 臺北信維郵局第 624 信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2017-07-05